Physiological severity of coronary artery stenosis

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 6, 2006, Pages

  Gould, K Lance ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DIPYRIDAMOLE; DOBUTAMINE;

ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; CLINICAL STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; EDITORIAL; HEART DISEASE; HEART MUSCLE ISCHEMIA; HUMAN; HYPEREMIA; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; REPRODUCIBILITY; REVASCULARIZATION; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

BLOOD FLOW VELOCITY; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; CORONARY STENOSIS; CORONARY VESSELS; FIBRINOLYTIC AGENTS; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; SEVERITY OF ILLNESS INDEX; THROMBOSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33845391289     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00488.2006     Document Type: Editorial

References (22)

1. Bech GJ, De BB, Bonnier HJ, Bartunek J, Wijns W, Peels K, Heyndrickx GR, Koolen JJ, and Pijls NH. Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. J Am Coll Cardiol 31: 841-847, 1998.
2. Berger A, Botman KJ, MacCarthy PA, Wijns W, Bartunek J, Heyndrickx GR, Pijls NH, and De Bruyne B. Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. J Am Coll Cardiol 46: 438-442, 2005.
3. Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, and Albers JJ. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345: 1583-1592, 2001.
4. Brown BG. Familial Atherosclerosis Treatment Study (FATS) 10-year follow-up: triple therapy reduces coronary events. Circulation 98: I-635, 1998.
5. DeBruyne B, Hersbach F, Pijls NHJ, Bartunek J, Bech JW, Heyndrickx Gould KL, and Wijns W. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but "normal" coronary angiography. Circulation 104: 2401-2406, 2001.
6. Gould KL. Coronary Artery Stenosis and Reversing Atherosclerosis (2nd Ed.). London: Arnold, and Oxford University Press. 1999.
7. Gould KL, Nakagawa Y, Nakagawa N, Sdringola S, Hess MJ, Haynie M, Parker N, and Kirkeeide R. Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base to apex, myocardial perfusion abnormalities by non-invasive positron emission tomography. Circulation 101: 1931-1939, 2000.
8. Gould KL, Lipscomb K, and Hamilton GW. A physiologic basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Amer J Cardiol 33: 87-94, 1974.
9. Gould KL. Pressure-flow characteristics of coronary stenoses in intact unsedated dogs at rest and during coronary vasodilation. Circ Res 43: 242-253, 1978.
10. Gould KL. Noninvasive assessment of coronary stenoses by myocardial imaging during coronary vasodilation. Part I Physiologic principles and experimental validation. Am J Cardiol 41: 267-278, 1978.
11. + and emission computed tomography in intact dogs. Am J Cardiol 43: 200-208, 1979.
12. Gould KL, Kirkeeide RL, and Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. Part I. Relative and absolute coronary flow reserve during changing aortic pressure and cardiac workload and Part II Determination from arteriographic stenosis dimensions under standardized conditions. J Am Coll Cardiol 15: 459-474, 1990.
13. Hueb W, Soares PR, Gersh BJ, Cesar LA, Luz PL, Puig LB, Martinez EM, Oliveira SA, and Ramires JA. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol 43: 1743-1751, 2004.
14. Katritsis DG and Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation 111: 2906-2912, 2005.
15. Kwok YS, Kim C, and Heidenreich PA. Medical therapy or coronary artery bypass graft surgery for chronic stable angina: an update using decision analysis. Am J Med 111: 89-95, 2001.
16. Kirkeeide R, Gould KL, and Parsel L. Assessment of coronary stenoses by myocardial imaging during coronary vasodilation. Part VII. Validation of coronary flow reserve as a single integrated measure of stenosis severity accounting for all it's geometric dimensions. J Am Coll Cardiol 7: 103-113, 1986.
17. v50 to assess the hemodynamic significance of coronary stenoses. Am J Physiol Heart Circ Physiol 291: H2630-H2635, 2006.
18. Pijls NHJ, van Son JAM, Kirkeeide RL, Bruyne BD, and Gould KL. Experimental basis of determining maximal coronary myocardial and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after PTCA. Circulation 86: 1354-1367, 1993.
19. Sdringola S, Nakagawa K, Nakagawa Y, Yusuf W, Mullani N, Haynie M, Hess MJ, and Gould KL. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual care cholesterol lowering drugs in coronary artery disease. J Am Coll Cardiol 41: 262-272, 2003.
20. Seiler C, Kirkeeide RL, and Gould KL. Basic structure-function of the epicardial coronary vascular tree - the basis of quantitative coronary arteriography for diffuse coronary artery disease. Circulation 85: 1987-2003, 1992.
21. Topol EJ, Ellis SG, Cosgrove DM, Bates ER, Muller DW, Schork NJ, Schork MA, and Loop FD. Analysis of coronary angioplasty practice in the United States with an insurance-claims database. Circulation 87: 1489-1497, 1993.
22. Wongpraparut N, Yalamanchili V, Pasnoori V, Satran A, Chandra M, Masden R, and Leesar MA. Thirty-month outcome after fractional flow reserve-guided versus conventional multivessel percutaneous coronary intervention. Am J Cardiol 96: 877-884, 2005.